D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the α(2C)-adrenergic receptor subtype

Neuroscience

Volumn 86, Issue 3, 1998, Pages 959-965

  Sallinen, J ^a   Haapalinna, A ^b   Viitamaa, T ^b   Kobilka, B K ^c   Scheinin, M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b ORION CORPORATION   (Finland)

^c STANFORD UNIVERSITY   (United States)

Author keywords

2 adrenoceptor subtypes; D amphetamine; Gene targeting; Locomotor activity; Serotonin syndrome; Transgenic mice

Indexed keywords

5 HYDROXYTRYPTOPHAN; ALPHA 2C ADRENERGIC RECEPTOR; DEXMEDETOMIDINE; DOPAMINE; RECEPTOR SUBTYPE; SEROTONIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE METABOLISM; GENETIC ENGINEERING; HEAD TWITCH; LOCOMOTION; MENTAL DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN METABOLISM; SEROTONIN SYNDROME;

5-HYDROXYTRYPTOPHAN; ADRENERGIC ALPHA-AGONISTS; ANIMALS; CROSSES, GENETIC; DEXTROAMPHETAMINE; FEMALE; GENE TARGETING; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMIDAZOLES; MALE; MEDETOMIDINE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN; SEX CHARACTERISTICS; STEREOTYPIC MOVEMENT DISORDER; SYNDROME;

EID: 0031862622     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00100-6     Document Type: Article

References (30)

1. Ahmed I. and Takeshita J. (1996) Clonidine: a critical review of its role in the treatment of psychiatric disorders. CNS Drugs 6, 53-70.
2. Curzon G. (1990) Stereotyped and other motor responses to 5-hydroxytryptamine receptor activation. In Neurobiology of Stereotyped Behaviour (eds Cooper S. J. and Dourish C. T.), Vol. 1, pp. 143-168. Oxford University Press, New York.
3. Essman W. D., McGonigle P. and Lucki I. (1993) Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and D-amphetamine. Psychopharmacology 112, 233-241.
4. Gerson S. C. and Baldessarini R. J. (1980) Motor effects of serotonin in the central nervous system. Life Sci. 27, 1435-1451.
5. 2-adrenoreceptors. Neuropharmacology 21, 507-510.
6. 2-adrenergic receptors. Molec. Pharmac. 40, 407-412.
7. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. A. (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmac. Rev. 246, 157-203.
8. 2-adrenoceptor subtypes to the antinociceptive action of dexmedetomidine and clonidine in rodent models of acute and chronic pain. Br. J. Pharmac. 120, 229P.
9. 2-adrenoceptor agonist. Pharmac. Toxicol. 72, 182-187.
10. Kuczenski R. and Segal D. S. (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9, 2051-2065.
11. Kuczenski R. and Segal D. S. (1992) Regional norepinephrine response to amphetamine using dialysis: comparison with caudate dopamine. Synapse 11, 164-169.
12. Kuczenski R. and Segal D. S. (1994) Neurochemistry of amphetamine. In Amphetamine and its Analogs: Psychopharmacology, Toxicology and Abuse (ed. Cho A. K.), Vol. 1, pp. 81-113. Academic, Orlando.
13. Layer R. T., Uretsky N. J. and Wallace L. J. (1992) Effect of serotonergic agonists in the nucleus accumbens on D-amphetamine-stimulated locomotion. Life Sci. 50, 813-820.
14. 2-adrenergic receptor subtypes b and c. Science 273, 803-805.
15. 2C-adrenoceptor homolog. Molec. Pharmac. 48, 48-55.
16. 2-adrenoceptor-subtype function. Trends pharmac. Sci. 18, 211-219.
17. MacDonald E., Scheinin M., Scheinin H. and Virtanen R. (1991) Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective α-2-adrenoceptor agonist. J. Pharmac. exp. Ther. 259, 848-854.
18. 2A-adrenergic receptor subtype. Science 273, 801-803.
19. Nagy A., Rossant J., Nagy R., Abramow-Newerly W. and Roder J. C. (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. natn. Acad. Sci. U.S.A. 90, 8424-8428.
20. Nicholas A. P., Hökfelt T. and Pieribone V. A. (1996) The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends pharmac. Sci. 17, 245-255.
21. Overbeek P. A., Aguilar-Cordova E., Hanten G., Schaffner D. L., Patel P., Lebovitz R. M. and Lieberman M. W. (1991) Coinjection strategy for visual identification of transgenic mice. Transgenic Res. 1, 31-37.
22. 2-adrenoceptor agonist. Eur. J. Pharmac. 306, 51-59.
23. 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. comp. Neurol. 372, 135-165.
24. 2-adrenoceptor agonist. Molec. Pharmac. 51, 36-46.
25. 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine. Eur. J. Pharmac. 195, 193-199.
26. 2-adrenoceptor blockade. Neuropsychopharmacology 15, 298-310.
27. Segal D. S. and Kuczenski R. (1994) Behavioral pharmacology of amphetamine. In Amphetamine and its Analogs: Psychopharmacology, Toxicology and Abuse (ed. Cho A. K.), Vol. 1, pp. 115-150. Academic, Orlando.
28. Sternbach H. (1991) The serotonin syndrome. Am. J. Psychiat. 148, 705-713.
29. 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. comp. Neurol. 372, 111-134.
30. Zetterström T., Sharp T., Marsden C. A. and Ungerstedt U. (1983) In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J. Neurochem. 41, 1769-1773.